01332 TOUYUN BIOTECH
- 0.190
- -0.028-12.84%
TOUYUN BIOTECH News
China Touyun Tech Widens Loss in 2023 Amid Lower Sales Orders
China Touyun Tech Group (HKG:1332) recorded an increase in attributable loss for 2023 to HK$268.9 million, from HK$198.1 million yuan a year ago, according to the company's annual report posted on the
透雲生物：2023年年報
Touyun Biotech Group Limited's (HKG:1332) 28% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio
Touyun Biotech Group Limited (HKG:1332) shares have retraced a considerable 28% in the last month, reversing a fair amount of their solid recent performance. For any long-term shareholders, the las
Touyun Biotech (01332) released annual results, losses attributable to shareholders of 269 million yuan, an increase of 35.78% year-on-year
According to the Zhitong Finance App, Touyun Biotech (01332) announced its annual results for the year ended December 31, 2023. The group achieved gross profit of HK$55.99 million during the period, a year-on-year decrease of 56.13%; shareholders' losses of 269 million yuan, an increase of 35.78% over the previous year; and a basic loss of 9.58 HK cents per share. According to the announcement, for the year ended 31 December 2023, the Group obtained revenue of approximately HK$198.6 million (2022: HK$315.8 million), a decrease of approximately 37.1% compared to last year. The decrease in turnover was mainly due to a decrease in sales orders for packaged products.
TOUYUN BIOTECH: ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2023
Touyun Biotech (01332.HK) held a board meeting on March 28 to approve publication of annual results
Gelonghui, March 14, 丨 Touyun Biotech (01332.HK) announced that the company will hold a board meeting on March 28, 2024 (Thursday) to approve (among other things) the publication of the annual results announcements of the company and its subsidiaries for the year ended 31 December 2023, and to consider the payment of a final dividend.
Touyun Biotech [01332] now reports HK$0.241, an increase of 14.22%
As of 15:02, Touyun Biotech [01332] reported HK$0.241, up HK$0.03 or 14.22% from yesterday's closing price, with a turnover of HK$40,700, today's high of HK$0.24 and the lowest price of HK$0.211. Based on yesterday's closing price, the 10-day average price was HK$0.17, and the 50-day average price was HK$0.26. The current price-earnings ratio was -2.99 times, and the 14-day strength and weakness index reported 54.97.
Some Confidence Is Lacking In Touyun Biotech Group Limited (HKG:1332) As Shares Slide 49%
The Touyun Biotech Group Limited (HKG:1332) share price has fared very poorly over the last month, falling by a substantial 49%. The drop over the last 30 days has capped off a tough year for share
TOUYUN BIOTECH: INTERIM REPORT 2023
Some Confidence Is Lacking In Touyun Biotech Group Limited (HKG:1332) As Shares Slide 26%
Touyun Biotech Group Limited (HKG:1332) shareholders won't be pleased to see that the share price has had a very rough month, dropping 26% and undoing the prior period's positive performance. The d
Touyun Biotech Group (HKG:1332) Is Making Moderate Use Of Debt
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously said that 'Volatility is far from synonymous with risk.' So it seems the smart m
Touyun Biotech (01332) Announces Interim Results, Shareholders' Share of Loss of HK$83.951 million narrowed 4.67% year-on-year
Touyun Biotech (01332) announced its interim results for the six months ended June 30, 2023. The group collected during the period...
TOUYUN BIOTECH: INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2023
Tuyun Biotech (01332.HK) will hold a board meeting on August 25 to approve the interim results
On August 11, GLONGWI | TOYUNBIO (01332.HK) announced that the company will hold a board meeting on August 25, 2023 to approve the publication of the company and its subsidiaries's interim results announcements for the six months ended June 30, 2023, and consider the payment of interim dividends.
TOUYUN BIOTECH: DATE OF BOARD MEETING
Touyun Biotech: 2022 Annual Report
Touyun Biotech: Annual Results Announcement for the Year Ended December 31, 2022
The 64% Return This Week Takes Touyun Biotech Group's (HKG:1332) Shareholders Three-year Gains to 224%
The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But if you buy shares in a really great company, you can more than double your money. To wit, the Touyun B
Cloud-penetrating organisms: interim report 2022
Is Touyun Biotech Group (HKG:1332) Using Too Much Debt?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that debt - which is usually involved in bankruptcies - is a very important factor, when
Analysis
Price Target
No Data
